Generation Bio Co. GBIO

$ 1.31 -2.96%

Quarterly report 2024-Q3
added 11-06-2024

Generation Bio Co. Balance Sheet 2011-2024 | GBIO

Annual Balance Sheet Generation Bio Co.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	31.4 M	-11.5 M	-300 M	-	-15.1 M	-7.3 M	-	-	-	-	-	-	-
Long Term Debt	89.8 M	74.6 M	76.2 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	8.12 M	7.09 M	4.61 M	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	132 M	119 M	-	-	-	-	-	-	-
Total Current Liabilities	39.9 M	19.2 M	18.8 M	11.2 M	-	-	-	-	-	-	-	-	-
Total Liabilities	172 M	93.8 M	95 M	26.1 M	141 M	125 M	-	-	-	-	-	-	-
Deferred Revenue	12.9 M	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-571 M	-445 M	-308 M	-189 M	-108 M	-47.1 M	-	-	-	-	-	-	-
Total Assets	375 M	376 M	477 M	294 M	42.1 M	83.5 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	66.4 M	93.2 M	381 M	64.9 M	17.2 M	9.47 M	-	-	-	-	-	-	-
Book Value	203 M	282 M	382 M	268 M	-98.6 M	-41.6 M	-	-	-	-	-	-	-
Total Shareholders Equity	203 M	282 M	382 M	268 M	-98.6 M	-41.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Generation Bio Co.

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	83 M	85.3 M	87.6 M	89.8 M	71 M	72.5 M	74.5 M	74.6 M	76.7 M	-	75.9 M	76.2 M	42.3 M	43.5 M	44.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	144 M	150 M	154 M	172 M	150 M	151 M	152 M	93.8 M	94 M	-	91.1 M	95 M	56.8 M	57.4 M	55.3 M	26.1 M	26.1 M	26.1 M	26.1 M	25.1 M	25.1 M	25.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	11.5 M	13.6 M	12.8 M	12.9 M	12 M	8.26 M	5.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-682 M	-666 M	-646 M	-571 M	-536 M	-508 M	-477 M	-445 M	-412 M	-	-343 M	-308 M	-277 M	-245 M	-215 M	-189 M	-189 M	-189 M	-189 M	-108 M	-108 M	-108 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	249 M	265 M	286 M	375 M	381 M	405 M	431 M	376 M	403 M	-	444 M	477 M	464 M	491 M	514 M	294 M	294 M	294 M	294 M	42.1 M	42.1 M	42.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	21.7 M	28.5 M	35.5 M	66.4 M	99.1 M	151 M	101 M	93.2 M	140 M	164 M	343 M	375 M	394 M	392 M	366 M	62.9 M	62.9 M	62.9 M	62.9 M	15.1 M	15.1 M	15.1 M	-	9.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	104 M	115 M	132 M	203 M	232 M	254 M	279 M	282 M	309 M	-	353 M	382 M	407 M	433 M	459 M	268 M	268 M	268 M	268 M	17 M	17 M	17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	104 M	115 M	132 M	203 M	232 M	254 M	279 M	282 M	309 M	325 M	353 M	382 M	407 M	433 M	459 M	268 M	268 M	268 M	268 M	-98.6 M	-98.6 M	-98.6 M	-54.7 M	-41.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency